Effectiveness of an intensive educational intervention for Computerized Physician Order Entry (CPOE)-mediated medication management in the outpatient clinic to increase quality of care and patient safety: a multicentre, cluster randomized, controlled trial and cost-effectiveness analysis

niversity Medical Centre Utrecht (Netherlands)0 个研究点目标入组 1,218 人开始时间: 2013年6月10日最近更新: 2019年7月15日

适应症

试验速览

•Eligibility of physicians for entering the trial:
•1. Physicians who work in a department where CPOE is available for a minimum of one month, and who received the standard training approach more than one month ago
•2. Physicians who work in an organisation where it is possible to log CPOE data - specialists and residents of internal medicine, cardiology, pulmonology, geriatrics, gastroenterology and rheumatology
•3. Physicians working at the outpatient clinic for at least 4 hours a week
•4. Physicians who agreed to participate in the study
•Eligibility of patients for participation:
•1. Patients older than 18 years old
•2. Patients visiting the outpatient clinic during the 4-week enrolment period, consulting a physician who is participating in the study

•For physicians:
•1. Physicians who were involved in the development of the educational intervention
•2. Physicians who work with a system that does not meet the basic requirements of a CPOE system, which are: possibility to store a current medication list and allergies, and basic decision support (drug-drug interaction, dose, duplicate order, contra-indications) (van der Sijs 2010)
•3. Physicians who work in an organisation that intends to change the CPOE system during the course of the study
•4. Physicians who work in an organisation that is undertaking interventions that might overlap with this intervention
•For patients:
•1. Patients who are unable to understand and talk Dutch or English
•2. Patients who have insufficient understanding of their medications to answer questions about their medicaments, or patients who do not have a caregiver who can answer the questions

发起方

niversity Medical Centre Utrecht (Netherlands)